Adalimumab treatment with and without methotrexate in patients with moderate to severe psoriatic arthritis: Results from adept

被引：0
|
作者：
Kavanaugh, AF
Ritchlin, CT
Malaise, MG
Wordsworth, P
Birbara, CA
Weinberg, MA
机构：
[1] UCSD, Ctr Innovat Therapy, Div Rheumatol Allergy & Immunol, La Jolla, CA USA
[2] Univ Liege, Dept Rheumatol, Liege, Belgium
[3] Univ Rochester, Sch Med & Dent, Rochester, NY USA
[4] Nuffield Orthopaed Ctr, Dept Rheumatol, Oxford OX3 7LD, England
[5] Univ Massachusetts, Sch Med, Worcester, MA USA
[6] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2005年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：325 / 325
页数：1
相关论文
共 50 条
  • [1] Adalimumab treatment effects on quality of life in patients with psoriatic arthritis: Results from adept
    Gladman, DD
    Mease, PJ
    Emery, R
    Wellborne, F
    Combe, B
    Weinberg, MA
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 317 - 317
  • [2] Adalimumab treatment effects on radiographic progression of joint disease in patients with psoriatic arthritis: Results from ADEPT
    Mease, PJ
    Sharp, JT
    Ory, P
    Gladman, DD
    Ritchlin, CT
    Choy, EH
    Weinberg, MA
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 320 - 320
  • [3] Adalimumab for treatment of moderate to severe psoriasis and psoriatic arthritis
    Bongiorno, M. R.
    Pistone, G.
    Doukaki, S.
    Arico, M.
    [J]. DERMATOLOGIC THERAPY, 2008, 21 : S15 - S20
  • [4] Adalimumab efficacy and safety results in patients with moderate to severe chronic plaque psoriasis with and without psoriatic arthritis
    Menter, MA
    Gordon, K
    Leonardi, C
    Chen, D
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P174 - P174
  • [5] IMPACT OF METHOTREXATE DOSE ON ADALIMUMAB EFFICACY IN PSORIATIC ARTHRITIS: A SUBANALYSIS OF ADEPT
    Aletaha, D.
    Li, Y.
    Hojnik, M.
    Ganz, F.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : 785 - 785
  • [6] Clinical efficacy, safety and inhibition of joint destruction of adalimumab in the treatment of moderate to severe psoriatic arthritis: 48-week results of the ADEPT trial
    Mease, P
    Gladman, D
    Ritchlin, C
    Weinberg, M
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB214 - AB214
  • [7] Safety and efficacy of adalimumab in combination with different doses of methotrexate in patients with psoriatic arthritis: Subanalysis of ADEPT
    Gottlieb, Allice
    Teixeira, Henrique D.
    Varothai, Nupun
    Ganz, Fabiana
    Valdecantos, Wendell C.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB268 - AB268
  • [8] Adalimumab is efficacious in treating skin disease in psoriatic arthritis: Subanalysis of moderate versus severe psoriasis in the ADEPT trial
    Gladman, D
    Mease, P
    Kavanaugh, A
    Weinberg, M
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB10 - AB11
  • [9] Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)
    Mease, P. J.
    Ory, P.
    Sharp, J. T.
    Ritchlin, C. T.
    Van den Bosch, F.
    Wellborne, F.
    Birbara, C.
    Thomson, G. T. D.
    Perdok, R. J.
    Medich, J.
    Wong, R. L.
    Gladman, D. D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (05) : 702 - 709
  • [10] Efficacy of secukinumab and adalimumab in psoriatic arthritis patients with moderate-to-severe plaque psoriasis: Results from the EXCEED study
    Gottlieb, Alice B.
    Merola, Joseph F.
    Reich, Kristian
    Behrens, Frank
    Nash, Peter
    Bao, Weibin
    Pellet, Pascale
    Pricop, Luminita
    McInnes, Iain B.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB92 - AB92
12345